What is Haemonetics's other working capital?

Haemonetics (HAE) reported other working capital of $5.98M in Q1 2026.

How has Haemonetics's other working capital changed year-over-year?

Haemonetics's other working capital increased by 220.5% year-over-year, from $1.86M to $5.98M.

What is the long-term trend for Haemonetics's other working capital?

Over 3 years (2023 to 2026), Haemonetics's other working capital has grown at a 4.8% compound annual growth rate (CAGR), from $9.32M to $10.73M.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Haemonetics HAE Other Working Capital

Other Working Capital at other companies

AbbottABT

$420M-3.7%

TFX

TeleflexTFX

$3.56M+367%

Boston ScientificBSX

$27M+486%

MedtronicMDT

$727M+20.0%

LivaNovaLIVN

-$1.17M-10,573%

ICU MedicalICUI

-$2.99M+67.6%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's other working capital?: Haemonetics (HAE) reported other working capital of $5.98M in Q1 2026.
How has Haemonetics's other working capital changed year-over-year?: Haemonetics's other working capital increased by 220.5% year-over-year, from $1.86M to $5.98M.
What is the long-term trend for Haemonetics's other working capital?: Over 3 years (2023 to 2026), Haemonetics's other working capital has grown at a 4.8% compound annual growth rate (CAGR), from $9.32M to $10.73M.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.